Trends in Age-Based Incidence of Esophageal Adenocarcinoma Over Time
Population-based analysis identified trends in incidence and disease-free survival for patients with advanced-stage carcinoma across 3 age groups.
Population-based analysis identified trends in incidence and disease-free survival for patients with advanced-stage carcinoma across 3 age groups.
Study finds correlation between certain laboratory markers and symptom burden in patients with relapsed/refractory multiple myeloma.
An analysis of patient outcomes revealed links between depression and HRQOL in patients with their informal caregivers’ level of health literacy.
A retrospective review of charts showed a high percentage of readmissions on an oncology service and 2 potential strategies for reducing this rate.
The efficacy and safety of direct oral anticoagulants and vitamin K antagonists in the treatment of ATEs/VTEs in patients with MPNs was compared.
Researchers compared adverse effect incidence with lapatinib administration at 3 different times of the day.
Population-based study evaluated survival outcomes for patients with cancer diagnosed over a 41-year period.
Patients with myelofibrosis conditioned with 2 alkylating agents may have better transplant outcomes compared with patients receiving 1 alkylating agent.
A recent analysis of insurance claims data revealed trends in ED visits, ICU visits, hospitalizations, and antineoplastic treatment at the end of life in this population.
In a new study, researchers reported on the frequency of VTE among more than 6000 patients who tested positive for infection with SARS-CoV-2.